Articles from Sempresto, Inc.

Sempresto, Inc., a medical device company pioneering smartphone-integrated rescue drug delivery, today announced the acquisition of all patents and related physical and digital assets from inventor Steven A. Friedman. Friedman’s innovations—focused on novel mechanisms and enhanced safety features for mobile device-integrated autoinjectors—provide key building blocks for Sempresto’s next-generation drug delivery platforms. This strategic acquisition further expands Sempresto’s intellectual property portfolio in cellphone-mounted and connected drug delivery systems.

Health Alliance Global, Inc. (Heal All), a leader in patientside diagnostic technologies and virtual care services staffed 24/7/365 by emergency medicine clinicians, and Sempresto, Inc., a Boston-based medical technology company developing smartphone-integrated rescue drug delivery devices, today announced a strategic collaboration to provide on-demand access to qualified medical providers in acute emergency situations to improve patient outcomes and reduce unnecessary ED visits.

Thomas Jefferson University and Sempresto, Inc. are pleased to announce an exclusive licensing agreement for a novel epinephrine autoinjector designed to improve accessibility and ease of use for patients with severe allergies. This breakthrough device, originally developed at Jefferson, will be further advanced and commercialized by Sempresto under the agreement.